Weekly Roundup – 10-24-08

J0262924As we enter the home stretch of the election cycle, I find myself wanting very badly for it to be November 5.  For me, this was once again another very busy week that included preparation for another speaking gig that is next week (see below).  Still, the weather has been beautiful and I took some time out for a special drive in the mountains to see the leaves.  Even nature is into Change We Can Believe In!

Here is a bit of what happened this week:

  1. GSK
  2. BMS
  3. J&J
  4. Abbott
  5. Novartis
  6. Roche
  7. Boehringer Ingelheim
  8. Astra Zeneca
  9. Pfizer
  10. Merck
  • DTC in the Era of Consumer Choice – I will be speaking at a conference next week put on by DTC Perspectives – the title of the conference being "DTC in the Era of Consumer Choice" to be held at the Westminster Hotel in Livingston, New Jersey on October 29-30.   My talk will be on preparing for coming pharmaceutical marketing and FDA reforms. 

That’s it for me this week.  And I absolutely promise that Monday will have the 3rd quarter review of Warning Letters!

Have a good weekend everyone. 

Share this:
Share this page via Email Share this page via Stumble Upon Share this page via Digg this Share this page via Facebook Share this page via Twitter
This entry was posted in Weekly Roundup. Bookmark the permalink.

Comments are closed.